ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2016
Results of Annual General Meeting held on 29 April 2016
AstraZeneca PLC announced the results of the voting at its Annual General
Meeting today. As proposed in the Notice of AGM, all Resolutions were decided
by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and
resolutions 9 - 11 were passed as special resolutions.
RESOLUTION VOTES FOR % VOTES % VOTES TOTAL
VOTES
OF AGAINST OF CAST IN VOTES
WITHHELD
VOTES VOTES TOTAL CAST
CAST CAST AS A
% OF
ISSUED
SHARE
CAPITAL
1 To receive 924,514,473 99.61 3,665,459 0.39 928,179,932 73.40%
8,998,621
the
Company's
Accounts and
the Reports
of the
Directors
and Auditor
for the
year ended
31 December
2015
2 To confirm 933,191,043 99.69 2,915,972 0.31 936,107,015 74.03%
1,071,537
dividends
3 To re 929,918,594 99.56 4,151,154 0.44 934,069,748 73.87%
3,108,804
-appoint
KPMG LLP,
London as
Auditor
4 To 934,984,319 99.89 988,556 0.11 935,972,875 74.02%
1,204,865
authorise
the
Directors to
agree the
remuneration
of the
Auditor
5a To re 861,678,834 94.69 48,321,545 5.31 910,000,379 71.96%
27,177,942
-elect Leif
Johansson as
a Director
5b To re 935,167,473 99.93 697,471 0.07 935,864,944 74.01%
1,342,796
-elect
Pascal
Soriot as a
Director
5c To re 931,875,086 99.58 3,920,615 0.42 935,795,701 74.00%
1,380,982
-elect Marc
Dunoyer as a
Director
5d To re 935,157,654 99.93 635,873 0.07 935,793,527 74.00%
1,384,110
-elect Cori
Bargmann as
a Director
5e To re 935,199,102 99.93 622,099 0.07 935,821,201 74.00%
1,356,436
-elect
Geneviève
Berger as a
Director
5f To re 933,026,505 99.70 2,762,355 0.30 935,788,860 74.00%
1,389,088
-elect Bruce
Burlington
as a
Director
5g To re 933,220,149 99.72 2,618,183 0.28 935,838,332 74.01%
1,339,989
-elect Ann
Cairns as a
Director
5h To re 919,686,570 98.97 9,526,012 1.03 929,212,582 73.48%
7,965,366
-elect
Graham
Chipchase as
a Director
5i To re 933,177,891 99.72 2,593,420 0.28 935,771,311 74.00%
1,406,637
-elect Jean
-Philippe
Courtois as
a Director
5j To re 923,984,532 98.74 11,766,347 1.26 935,750,879 74.00%
1,427,442
-elect Rudy
Markham as a
Director
5k To re 927,479,182 99.11 8,287,726 0.89 935,766,908 74.00%
1,410,552
-elect
Shriti
Vadera as a
Director
5l To re 870,828,312 95.76 38,511,577 4.24 909,339,889 71.91%
27,837,158
-elect
Marcus
Wallenberg
as a
Director
6 To approve 836,396,151 89.61 96,959,428 10.39 933,355,579 73.81%
3,822,290
the Annual
Report on
Remuneration
for the year
ended 31
December
2015
7 To 908,106,542 97.83 20,185,176 2.17 928,291,718 73.41%
8,886,009
authorise
limited EU
political
donations
8 To 849,809,843 90.97 84,303,774 9.03 934,113,617 73.87%
3,064,122
authorise
the
Directors to
allot shares
9 To 922,425,478 98.82 11,009,374 1.18 933,434,852 73.82%
3,742,888
authorise
the
Directors to
disapply pre
-emption
rights
10 To 926,166,577 98.96 9,722,078 1.04 935,888,655 74.01%
1,289,613
authorise
the Company
to purchase
its own
shares
11 To reduce 829,946,353 88.85 104,116,202 11.15 934,062,555 73.87%
3,115,081
the notice
period for
general
meetings
Issued capital
As at 27 April 2016, the number of issued shares of the Company was
1,264,542,488 ordinary shares, which was the total number of shares entitling
the holders to attend and vote for or against all the resolutions at the AGM.
In accordance with the Company's Articles of Association, on a poll every member
present in person or by proxy has one vote for every share held.
A C N Kemp
Company Secretary
29 April 2016
Result of AGM
| Quelle: AstraZeneca PLC